Sean P. Palecek

Professor

University of Wisconsin-Madison
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (8)

Brain microvascular endothelial cells (BMECs) forming the blood-brain barrier (BBB) maintain brain homeostasis through specialized properties such as tight junctions, efflux transporters, and low levels of transcytosis. However, mechanisms governing induction of BBB properties during development remain poorly understood. We mined single-cell RNA sequencing datasets to identify transcription factors (TFs) critical for BBB development. Forty-four TFs were overexpressed in human pluripotent stem cell-derived endothelial cells cultured in the presence of the Wnt pathway agonist CHIR99021 to identify TFs capable of directing acquisition of BBB properties via forward programming. Individual TFs, including KLF2 , KLF4 , FOXF1 , FOXF2 , ZIC2 , ZIC3 , NR4A1 , NR4A2 , FOXC1 , and FOXQ1 , induced distinct BBB-like gene expression patterns. Combinations of these TFs induced many canonical BBB genes, yielding ECs with reduced endocytosis, increased efflux activity, and improved barrier function. The resultant forward programmed CNS-like ECs (fpCECs) offer promising tools for modeling human BBB development and neurovascular disease and for drug screening.

Year:

2026

Protocols for generating cardiomyocytes (CMs) from human pluripotent stem cells (hPSCs) have existed for nearly two decades, yet manufacturing variability in terminal cell identity continues to limit clinical translation. To uncover the origin of fate divergence during hPSC-CM differentiation, we performed temporal transcriptomics, proteomics, and metabolomics of high and low efficiency differentiations. We identified significant early multi-omic divergence between differentiation batches and key pathways underlying fate divergence at critical differentiation stages included Wnt, MAPK, and glucose metabolism. Machine learning models trained on early candidate gene markers predicted hPSC-CM purity better than models using canonical cardiac development markers. Lastly, multi-omic insights informed perturbations, including Wnt and MAPK inhibition, which produced higher CM purities and yields. Our results showcase multi-omic analysis coupled with machine learning models as a powerful tool to identify cell fate determinants and enable robust manufacturing of complex cell products such as hPSC-derived cell therapies. Teaser Multi-omic analysis of hPSC-CM differentiation efficiency reveals early predictive features and enables robust differentiation.

Year:

2026

Endothelial cells throughout the body sense blood flow, eliciting transcriptional and phenotypic responses. The brain endothelium, known as the blood–brain barrier (BBB), possesses unique barrier and transport properties, which are in part regulated by blood flow. We utilized RNA sequencing to analyze the transcriptome of primary cultured rat brain microvascular endothelial cells (BMECs), as well as three human induced pluripotent stem cell-derived models. We compared the transcriptional responses of these cells to either low (0.5 dyne/cm2) or high (12 dyne/cm2) shear stresses, and subsequent analyses identified genes and pathways that were influenced by shear including key BBB-associated genes (SLC2A1, LSR, PLVAP) and canonical endothelial shear-stress-response transcription factors (KLF2, KLF4). In addition, our analysis suggests that shear alone is insufficient to rescue the de-differentiation caused by in vitro primary BMEC culture. Overall, these datasets and analyses provide new insights into the influence of shear on BBB models that will aid in model selection and guide further model development.

Year:

2025

Maturing human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) in vitro is critical for advancing drug discovery and cardiotoxicity screening applications of these cells. However, the metabolic compositions of basal media used for hPSC-CM culture typically offer limited relevance to human cardiac physiology. Here, we examined how culture in Human Plasma-Like Medium (HPLM) versus conventional basal media affects the behavior of hPSC-CMs. Starting with Day 16 hPSC-CMs, we cultured cells for two weeks in either HPLM or RPMI-based media and then assessed maturation outcomes at Day 30. Compared to RPMI/B27 media containing either RPMI-defined (11.1 mM) or physiologic glucose levels (5 mM), HPLM/B27 markedly enhanced hPSC-CM maturity as evinced by concerted transcriptomic, structural, functional, and metabolic phenotypes. These effects included a higher extent of myosin heavy chain isoform switching (α-MHC to β-MHC), accelerated ventricular-specific myosin light chain isoform switching (MLC2a to MLC2v), elongated sarcomeres, increased multinucleation, enhanced calcium transient kinetics, and coordinated activation of oxidative and glycolytic metabolism. Collectively, these findings demonstrate that medium composition has substantial effects on hPSC-CM biology and also establish HPLM as a tool for driving hPSC-CM maturation in vitro . Translational Impact Statement HPLM was designed to more closely recapitulate the metabolic composition of human plasma and thus provides a physiological platform to promote hPSC-CM maturation. By enhancing structural, functional, and metabolic maturity, HPLM-cultured hPSC-CMs better approximate cardiac physiology, positioning them as improved models for cardiovascular disease research, drug-induced cardiotoxicity screening, and personalized therapeutic testing. This medium can integrate with existing maturation strategies, accelerating the translation of basic cardiac research into clinically predictive tools for the drug development pipeline. Graphical Abstract

Year:

2025

Human pluripotent stem cell (hPSC)-derived cardiac therapies hold great promise for heart regeneration but face major translational barriers due to allogeneic immune rejection. Here, we engineered hypoimmunogenic hPSCs using a two-step CRISPR-Cas9 strategy: (1) B2M knockout, eliminating HLA class I surface expression, and (2) knock-in of HLA-E or HLA-G trimer constructs in the AAVS1 safe harbor locus to confer robust immune evasion. Hypoimmunogenic hPSCs maintained pluripotency, efficiently differentiated into cardiac cell types that resisted both T and NK cell-mediated cytotoxicity in vitro , and self-assembled into engineered cardiac organoids. Comprehensive analyses of the hypoimmunogenic cells and organoids revealed preservation of transcriptomic, structural, and functional properties with minimal off-target effects from gene editing. In vivo , hypoimmunogenic cardiac organoids restored contractile function in infarcted rat hearts and demonstrated superior graft retention and immune evasion in humanized mice compared to wild-type counterparts. These findings establish the therapeutic potential of hypoimmunogenic hPSC-CMs in the cardiac organoid platform, laying the foundation for off-the-shelf cardiac cell therapies to treat cardiovascular disease, the leading cause of death worldwide.

Year:

2025

We present an iterative workflow that integrates computational modeling with in vitro experiments to discover synthetic α/β-peptides with high selectivities against Candida albicans , a fungal pathogen associated with high mortality rates.

Year:

2025

Atrial fibrosis is central to the pathology of heart failure (HF) and atrial fibrillation (AF). Identifying precise mechanisms underlying atrial fibrosis will provide effective strategies for clinical intervention. This study investigates a metabolic serine threonine kinase gene, sucrose non-fermenting related kinase (SNRK), that we previously reported to control cardiac metabolism and function. Conditional knockout of Snrk in mouse cardiomyocytes ( Snrk cmcKO) leads to atrial fibrosis and subsequently HF. The precise mechanism underlying cardiomyocyte SNRK-driven repression of fibrosis is not known. Here, using mouse, rat, and human tissues, we demonstrate that SNRK expression is high in atria, especially in atrial cardiomyocytes. SNRK expression correlates with lower levels of pro-fibrotic protein transforming growth factor-beta 1 (TGFβ1) in the atrial cardiomyocytes. In HL-1 adult immortalized mouse atrial cells, using siRNA approaches, we show that Snrk knockdown cells show more TGFβ1 secretion, which was also observed in heart lysates from Snrk cardiac-specific knockout mice in vivo. These effects were exacerbated upon infusion of Angiotensin II. Results from Snrk knockdown cardiomyocytes co-cultured with cardiac fibroblasts suggest that SNRK represses TGFβ1 signaling (Smad 2/3) in atrial CMs and prevents paracrine cardiac fibroblast activation (α-SMA marker). In conclusion, high SNRK expression in atria regulates cardiac homeostasis, by preventing the release of TGFβ1 secretion to block cardiac fibrosis. These studies will assist in developing heart chamber-specific fibrosis therapy for non-ischemic HF and AF.

Year:

2024

Year:

2023

Collaborators (15)

Melissa Skala

Professor

University of Wisconsin-Madison

UNITED STATES
View details

Xiaoping Bao

Associate Professor

Purdue University

UNITED STATES
View details

Yunfeng Ding

Researcher

University of Wisconsin-Madison

UNITED STATES
View details

Timothy Kamp

Professor

University of Wisconsin-Madison

UNITED STATES
View details

Benjamin Gastfriend

University of California, San Diego

UNITED STATES
View details

David M. Lynn

-

UNITED STATES
View details

Leonardo Ferreira

Assistant Professor

Medical University of South Carolina

UNITED STATES
View details

Reid C. Van Lehn

University of Wisconsin-Madison

UNITED STATES
View details

Xiaojun Lian

Associate Professor

Pennsylvania State University

UNITED STATES
View details

Richard Daneman

Associate Professor

University of California

UNITED STATES
View details

Moriah Katt

Assistant Professor

West Virginia University

UNITED STATES
View details

Ying Mei

Clemson University

UNITED STATES
View details

Russell Norris

Professor

Medical University of South Carolina

UNITED STATES
View details

Ramani Ramchandran

Professor

Medical College of Wisconsin

UNITED STATES
View details

Eric V. Shusta

University of Wisconsin-Madison

UNITED STATES
View details